Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biolargo Inc BLGO

Chemicals Specialty Chemicals
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental... see more

Recent & Breaking News (OTCQX:BLGO)

Dennis P. Calvert, President & CEO of BioLargo, Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com

GlobeNewswire June 8, 2020

BioLargo Discusses Clyraguard, BioLargo PFAS Treatment Technology Scale-up and Commercialization, and Progress of South Korean Joint Venture with The Stock Day Podcast

Newsfile June 4, 2020

Johnny Sirpilla Joins BioLargo's Subsidiary Clyra Medical Technologies as Chief Business Development Officer

Accesswire June 2, 2020

BioLargo Granted Expanded Patent Coverage for its AOS Water Treatment Technology

Accesswire May 28, 2020

Shawn Dougherty Joins BioLargo's Subsidiary Clyra Medical Technologies as Chief Revenue Officer

Accesswire May 26, 2020

BioLargo's CupriDyne Technology Proven Effective at Inactivating SARS-CoV-2

Accesswire May 21, 2020

BioLargo Subsidiary Clyra Medical's Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study

Accesswire May 19, 2020

BioLargo 2019 Annual Report Highlights Record Revenues, New Channel Partnerships, and Commercialization Milestones

GlobeNewswire March 31, 2020

BioLargo Continuing Operations Through the COVID-19 Crisis

GlobeNewswire March 23, 2020

BioLargo, BKT, and Tomorrow Water Set to Launch Joint Venture to Manufacture and Distribute CupriDyne Clean Based Products in South Korea

GlobeNewswire March 18, 2020

BioLargo Reveals Scaled Up Commercial Design for AOS Water Treatment Technology

GlobeNewswire March 17, 2020

BioLargo, Inc. Updates The Stock Day Podcast On Commercialization of PFAS Solution

Newsfile March 9, 2020

BioLargo, Inc. to Present March 3rd at the 2020 LD Micro Virtual Conference

Accesswire March 2, 2020

BioLargo Announces Crowdfunding Offering of Water Subsidiary Opportunity to Invest in Water Treatment Technology

PR Newswire February 19, 2020

BioLargo Expands Global Reach, Signs Joint Venture Agreement with BKT & Tomorrow Water Featuring CupriDyne Clean Based Products

GlobeNewswire February 12, 2020

BioLargo Engineering Is Tackling PFAS Head-On With New Treatment Technology and is Moving To Next Phase Of Groundbreaking PFAS Work

GlobeNewswire January 29, 2020

BioLargo Discusses 2020 Growth Strategy with the Stock Day Podcast

Newsfile January 15, 2020

BioLargo Welcomes Water Industry Veteran Tonya Chandler to its Sales and Marketing Team

GlobeNewswire January 14, 2020

BioLargo Continues Record-Breaking Revenue Growth

GlobeNewswire January 13, 2020

BioLargo Discusses Its 2020 Growth Strategy with the Stock Day Podcast

Newsfile December 11, 2019